|
|
|
|
Trial | Studied trt | Control trt | patients | tags | ROB | Trial result | cardiovascular events | Cardiovascular death |
---|
|
Yang, 2015 NCT | dapagliflozin | | | | | - | | |
Nauck, 2011 NCT | dapagliflozin | dlipizide add on metformin | | | | - | | |
Ferrannini (MB102013), 2010 NCT | dapagliflozin | placebo | | | Low risk of bias | - | | |
Komoroski (MB102007), 2009 NCT | dapagliflozin | placebo | | | Exploratory | - | | |
List (MB102008), 2009 NCT | dapagliflozin | placebo | | | Exploratory | - | | |
KOhan NCT | dapagliflozin | placebo | | | Low risk of bias | - | | |
Kohan NCT | dapagliflozin | placebo | | | | - | | |
Kohan NCT | dapagliflozin | placebo | | | | - | | |
DECLARE TIMI 58, 2018 NCT | dapagliflozin | placebo | | | Low risk of bias | - | | |
Kaku, 2014 NCT | dapagliflozin | placebo | | | | - | | |
Wilding (MB102009), 2009 NCT | dapagliflozin | placebo (add on insulin) | | | Low risk of bias | - | | |
Wilding, 2012 NCT | dapagliflozin | placebo (add on insulin) | | | | - | | |
Mathieu, 2015 NCT | dapagliflozin | placebo (add on MET + SAXA) | | | | - | | |
Bailey (MB102014), 2010 NCT | dapagliflozin | placebo (add on MET) | | | Low risk of bias | - | | |
Bolinder, 2012 NCT | dapagliflozin | placebo (add on MET) | | | | - | | |
Schumm-Draeger , 2015 NCT | dapagliflozin | placebo (add on MET) | | | | - | | |
Matthaei, 2015 NCT | dapagliflozin | placebo (add on MET+SU) | | | | - | | |
Rosenstock, 2012 NCT | dapagliflozin | placebo (add on TZD) | | | | - | | |
MB102035 NCT | dapagliflozin | placebo (on top standard treatment) | | | | - | | |
Cefalu, 2015 NCT | dapagliflozin | placebo (on top standard treatment) | | | | - | | |
Leiter, 2016 NCT | dapagliflozin | placebo (on top standard treatment) | | | | - | | |
MB102073 NCT | dapagliflozin | placebo (on top standard treatment) | | | | - | | |
Weber NCT | dapagliflozin | placebo (on top standard treatment) | | | | - | | |
MB102061 NCT | dapagliflozin | placebo add on DPP-4 | | | | - | | |
Rosenstock, 2015 NCT | dapagliflozin | Saxagliptin (add on MET) | | | | - | | |
Kohan NCT | dapagliflozin + merformin | dapagliflozin | | | | - | | |
Strojek, 2011 NCT | dapagliflozin + Glimepiride | glimepiride | | | | - | | |
MB102034, 2016 NCT | dapagliflozin + merformin | metformin or dapa | | | | - | | |